3D-printed solid oral dosage forms for mental and neurological disorders: recent advances and future perspectives

References

• World mental health report: transforming mental health for all. [Internet]. Geneva: World Health Organization; 2022. Available from: https://www.who.int/publications/i/item/9789240049338
   Google Scholar
• Schiele JT, Quinzler R, Klimm H-D, et al. Difficulties swallowing solid oral dosage forms in a general practice population: prevalence, causes, and relationship to dosage forms. Eur J Clin Pharmacol. 2013;69(4):937–948. doi: 10.1007/s00228-012-1417-0
   PubMed Web of Science ®Google Scholar
• Lipp MM, Hickey AJ, Langer R, et al. A technology evaluation of CVT-301 (inbrija): an inhalable therapy for treatment of Parkinson’s disease. Expert Opin Drug Delivery. 2021;18(11):1559–1569. doi: 10.1080/17425247.2021.1960820
   PubMed Web of Science ®Google Scholar
• Canady VA. FDA approves esketamine treatment for MDD, suicidal ideation. Mental Health Weekly. 2020;30(31):6–7. doi: 10.1002/mhw.32471
   Google Scholar
• Lee KC, Chen JJ. Transdermal selegiline for the treatment of major depressive disorder. Neuropsychiatr Dis Treat. 2007;3(5):527–537.
   PubMedGoogle Scholar
• Goetz LH, Schork NJ. Personalized medicine: motivation, challenges, and progress. Fertil Sterility. 2018;109(6):952–963. doi: 10.1016/j.fertnstert.2018.05.006
   PubMed Web of Science ®Google Scholar
• Robles-Martinez P, Xu X, Trenfield SJ, et al. 3D printing of a multi-layered polypill containing six drugs using a novel stereolithographic method. Pharmaceutics. 2019;11:274. doi: 10.3390/pharmaceutics11060274
   PubMed Web of Science ®Google Scholar
• Goh WJ, Tan SX, Pastorin G, et al. 3D printing of four-in-one oral polypill with multiple release profiles for personalized delivery of caffeine and vitamin B analogues. Int J Pharmaceut. 2021;598:120360. doi: 10.1016/j.ijpharm.2021.120360
   PubMed Web of Science ®Google Scholar
• Tabriz AG, Nandi U, Scoutaris N, et al. Personalised paediatric chewable Ibuprofen tablets fabricated using 3D micro-extrusion printing technology. Int J Pharmaceut. 2022;626:122135. doi: 10.1016/j.ijpharm.2022.122135
   PubMed Web of Science ®Google Scholar
• Karavasili C, Gkaragkounis A, Moschakis T, et al. Pediatric-friendly chocolate-based dosage forms for the oral administration of both hydrophilic and lipophilic drugs fabricated with extrusion-based 3D printing. Eur J Pharmaceut Sci. 2020;147:105291. doi: 10.1016/j.ejps.2020.105291
   PubMed Web of Science ®Google Scholar
• Scoutaris N, Ross SA, Douroumis D. 3D printed “starmix” drug loaded dosage forms for paediatric applications. Pharm Res. 2018;35:34.
   PubMed Web of Science ®Google Scholar
• Gander C, Shi K, Nokhodchi A, et al. A review of the benefits 3D printing brings to patients with neurological diseases. Pharmaceutics. 2023;15(3):892. doi: 10.3390/pharmaceutics15030892
   PubMed Web of Science ®Google Scholar
• Souto EB, Campos JC, Filho SC, et al. 3D printing in the design of pharmaceutical dosage forms. Pharm Dev Technol. 2019;24(8):1044–1053. doi: 10.1080/10837450.2019.1630426
   PubMed Web of Science ®Google Scholar
• Guo N, Leu MC. Additive manufacturing: technology, applications and research needs. Front Mech Eng. 2013;8(3):215–243. doi: 10.1007/s11465-013-0248-8
   Google Scholar
• Quan H, Zhang T, Xu H, et al. Photo-curing 3D printing technique and its challenges. Bioact Mater. 2020;5(1):110–115. doi: 10.1016/j.bioactmat.2019.12.003
   PubMed Web of Science ®Google Scholar
• El Aita I, Ponsar H, Quodbach J. A critical review on 3D-printed dosage forms. CPD. 2019;24(42):4957–4978. doi: 10.2174/1381612825666181206124206
   Google Scholar
• Melchels FPW, Feijen J, Grijpma DW. A review on stereolithography and its applications in biomedical engineering. Biomaterials. 2010;31(24):6121–6130. doi: 10.1016/j.biomaterials.2010.04.050
   PubMed Web of Science ®Google Scholar
• Goole J, Amighi K. 3D printing in pharmaceutics: a new tool for designing customized drug delivery systems. Int J Pharmaceut. 2016;499:376–394. doi: 10.1016/j.ijpharm.2015.12.071
   PubMed Web of Science ®Google Scholar
• Zhang J, Vo AQ, Feng X, et al. Pharmaceutical Additive manufacturing: a novel tool for complex and personalized drug delivery systems. AAPS Pharm Sci Tech. 2018;19(8):3388–3402. doi: 10.1208/s12249-018-1097-x
   PubMed Web of Science ®Google Scholar
• Duan B, Cheung WL, Wang M. Optimized fabrication of ca–P/PHBV nanocomposite scaffolds via selective laser sintering for bone tissue engineering. Biofabrication. 2011;3(1):015001. doi: 10.1088/1758-5082/3/1/015001
   PubMed Web of Science ®Google Scholar
• Awad A, Fina F, Goyanes A, et al. 3D printing: principles and pharmaceutical applications of selective laser sintering. Int J Pharmaceut. 2020;586:119594. doi: 10.1016/j.ijpharm.2020.119594
   PubMed Web of Science ®Google Scholar
• Guo Y, Patanwala HS, Bognet B, et al. Inkjet and inkjet-based 3D printing: connecting fluid properties and printing performance. RPJ. 2017;23(3):562–576. doi: 10.1108/RPJ-05-2016-0076
   Google Scholar
• Yu D-G, Branford-White C, Yang Y-C, et al. A novel fast disintegrating tablet fabricated by three-dimensional printing. Drug Dev Ind Pharm. 2009;35(12):1530–1536. doi: 10.3109/03639040903059359
   PubMed Web of Science ®Google Scholar
• Yu DG, Yang XL, Huang WD, et al. Tablets with material gradients fabricated by three-dimensional printing. J Pharmaceut sci. 2007;96(9):2446–2456. doi: 10.1002/jps.20864
   PubMed Web of Science ®Google Scholar
• Katstra WE, Palazzolo RD, Rowe CW, et al. Oral dosage forms fabricated by three dimensional printing™. JControlled Release. 2000;66(1):1–9. doi: 10.1016/S0168-3659(99)00225-4
   PubMed Web of Science ®Google Scholar
• Lee K-J, Kang A, Delfino JJ, et al. Evaluation of Critical Formulation Factors in the Development of a Rapidly Dispersing Captopril Oral Dosage Form. Drug Dev Ind Pharm. 2003;29(9):967–979. doi: 10.1081/DDC-120025454
   PubMed Web of Science ®Google Scholar
• Wang C-C, Tejwani (Motwani) MR, Roach WJ, et al. Development of near zero-order release dosage forms using three-dimensional printing (3-DP™) technology. Drug Dev Ind Pharm. 2006;32(3):367–376. doi: 10.1080/03639040500519300
   PubMed Web of Science ®Google Scholar
• Dumpa N, Butreddy A, Wang H, et al. 3D printing in personalized drug delivery: An overview of hot-melt extrusion-based fused deposition modeling. Int J Pharmaceut. 2021;600:120501. doi: 10.1016/j.ijpharm.2021.120501
   PubMed Web of Science ®Google Scholar
• Pietrzak K, Isreb A, Alhnan MA. A flexible-dose dispenser for immediate and extended release 3D printed tablets. Eur J Pharm Biopharm. 2015;96:380–387. doi: 10.1016/j.ejpb.2015.07.027
   PubMed Web of Science ®Google Scholar
• Goyanes A, Robles Martinez P, Buanz A, et al. Effect of geometry on drug release from 3D printed tablets. Int J Pharmaceut. 2015;494(2):657–663. doi: 10.1016/j.ijpharm.2015.04.069
   PubMed Web of Science ®Google Scholar
• Auriemma G, Tommasino C, Falcone G, et al. Additive manufacturing strategies for personalized drug delivery systems and medical devices: fused filament Fabrication and semi solid extrusion. Molecules. 2022;27(9):2784. doi: 10.3390/molecules27092784
   PubMed Web of Science ®Google Scholar
• Díaz-Torres E, Rodríguez-Pombo L, Ong JJ, et al. Integrating pressure sensor control into semi-solid extrusion 3D printing to optimize medicine manufacturing. Int J Pharm X. 2022;4:100133. doi: 10.1016/j.ijpx.2022.100133
   PubMedGoogle Scholar
• Tashman JW, Shiwarski DJ, Feinberg AW. A high performance open-source syringe extruder optimized for extrusion and retraction during FRESH 3D bioprinting. HardwareX. 2021;9:e00170. doi: 10.1016/j.ohx.2020.e00170
   PubMedGoogle Scholar
• Zhang Q, Yan D, Zhang K, et al. Pattern transformation of heat-shrinkable polymer by three-dimensional (3D) printing technique. Sci Rep. 2015;5(1):8936. doi: 10.1038/srep08936
   PubMedGoogle Scholar
• Solis DM, Czekanski A. The effect of the printing temperature on 4D DLP printed pNIPAM hydrogels. Soft Matter. 2022;18(17):3422–3429. doi: 10.1039/D2SM00201A
   PubMed Web of Science ®Google Scholar
• Cui C, Kim D-O, Pack MY, et al. 4D printing of self-folding and cell-encapsulating 3D microstructures as scaffolds for tissue-engineering applications. Biofabrication. 2020;12(4):045018. doi: 10.1088/1758-5090/aba502
   PubMed Web of Science ®Google Scholar
• Chu H, Yang W, Sun L, et al. 4D printing: a review on recent progresses. Micromach. 2020;11:796. doi: 10.3390/mi11090796
   PubMed Web of Science ®Google Scholar
• Fitzgerald S. FDA approves first 3D-Printed epilepsy drug experts assess the benefits and caveats. Neurology Today. 2015;15(18):26. doi: 10.1097/01.NT.0000472137.66046.b5
   Google Scholar
• Home - SPRITAM ® (levetiracetam) [Internet]. [cited 2023 Mar 1]. Available from: https://spritam.com/
   Google Scholar
• Triastec Inc. About Triastek [Internet]. [cited 2023 Jul 17]. Available from: https://www.triastek.com/
   Google Scholar
• Cui M, Pan H, Fang D, et al. Fabrication of high drug loading levetiracetam tablets using semi-solid extrusion 3D printing. J Drug Delivery Sci Technol. 2020;57:101683. doi: 10.1016/j.jddst.2020.101683
   Web of Science ®Google Scholar
• Cui M, Li Y, Wang S, et al. Exploration and preparation of a dose-flexible Regulation system for levetiracetam tablets via novel semi-solid extrusion three-dimensional printing. J Pharmaceut sci. 2019;108(2):977–986. doi: 10.1016/j.xphs.2018.10.001
   PubMed Web of Science ®Google Scholar
• El Aita I, Rahman J, Breitkreutz J, et al. 3D-Printing with precise layer-wise dose adjustments for paediatric use via pressure-assisted microsyringe printing. Eur J Pharm Biopharm. 2020;157:59–65. doi: 10.1016/j.ejpb.2020.09.012
   PubMed Web of Science ®Google Scholar
• El Aita I, Breitkreutz J, Quodbach J. On-demand manufacturing of immediate release levetiracetam tablets using pressure-assisted microsyringe printing. Eur J Pharm Biopharm. 2019;134:29–36. doi: 10.1016/j.ejpb.2018.11.008
   PubMed Web of Science ®Google Scholar
• Sjöholm E, Mathiyalagan R, Lindfors L, et al. Semi-solid extrusion 3D printing of tailored ChewTs for veterinary use - a focus on spectrophotometric quantification of gabapentin. Eur J Pharmaceut Sci. 2022;174:106190. doi: 10.1016/j.ejps.2022.106190
   PubMed Web of Science ®Google Scholar
• Hong X, Han X, Li X, et al. Binder jet 3D printing of compound LEV-PN dispersible tablets: an innovative approach for Fabricating drug systems with multicompartmental structures. Pharmaceutics. 2021;13(11):1780. doi: 10.3390/pharmaceutics13111780
   PubMed Web of Science ®Google Scholar
• Li X, Liang E, Hong X, et al. In vitro and in vivo bioequivalence study of 3D-Printed instant-dissolving levetiracetam tablets and subsequent personalized dosing for Chinese children based on Physiological pharmacokinetic modeling. Pharmaceutics. 2022;14(1):20. doi: 10.3390/pharmaceutics14010020
   Web of Science ®Google Scholar
• Panraksa P, Zhang B, Rachtanapun P, et al. ‘Tablet-in-syringe’: a novel dosing mechanism for dysphagic patients containing fast-disintegrating tablets fabricated using semisolid extrusion 3D printing. Pharmaceutics. 2022;14(2):443. doi: 10.3390/pharmaceutics14020443
   PubMed Web of Science ®Google Scholar
• Conceição J, Farto-Vaamonde X, Goyanes A, et al. Hydroxypropyl-β-cyclodextrin-based fast dissolving carbamazepine printlets prepared by semisolid extrusion 3D printing. Carbohydr Polym. 2019;221:55–62. doi: 10.1016/j.carbpol.2019.05.084
   PubMed Web of Science ®Google Scholar
• Hu J, Fitaihi R, Abukhamees S, et al. Formulation and characterisation of carbamazepine orodispersible 3D-Printed mini-tablets for paediatric use. Pharmaceutics. 2023;15(1):250. doi: 10.3390/pharmaceutics15010250
   PubMed Web of Science ®Google Scholar
• Lamichhane S, Park J-B, Sohn DH, et al. Customized novel design of 3D printed Pregabalin tablets for intra-gastric floating and controlled release using fused deposition modeling. Pharmaceutics. 2019;11(11):564. doi: 10.3390/pharmaceutics11110564
   PubMed Web of Science ®Google Scholar
• Rajora A, Nagpal K. A critical review on floating tablets as a tool for achieving better gastric retention. Crit Rev Ther Drug Carrier Syst. 2022;39(1):65–103. doi: 10.1615/CritRevTherDrugCarrierSyst.2021038568
   PubMed Web of Science ®Google Scholar
• Stops F, Fell JT, Collett JH, et al. The use of citric acid to prolong the in vivo gastro-retention of a floating dosage form in the fasted state. Int J Pharmaceut. 2006;308(1–2):8–13. doi: 10.1016/j.ijpharm.2005.09.036
   PubMed Web of Science ®Google Scholar
• Homaee Borujeni S, Mirdamadian SZ, Varshosaz J, et al. Three-dimensional (3D) printed tablets using ethyl cellulose and hydroxypropyl cellulose to achieve zero order sustained release profile. Cellul. 2020;27(3):1573–1589. doi: 10.1007/s10570-019-02881-4
   Web of Science ®Google Scholar
• Tagami T, Morimura C, Ozeki T. Effective and simple prediction model of drug release from “ghost tablets” fabricated using a digital light projection-type 3D printer. Int J Pharmaceut. 2021;604:120721. doi: 10.1016/j.ijpharm.2021.120721
   PubMed Web of Science ®Google Scholar
• Saydam M, Takka S. Improving the dissolution of a water-insoluble orphan drug through a fused deposition modelling 3-dimensional printing technology approach. Eur J Pharmaceut Sci. 2020;152:105426. doi: 10.1016/j.ejps.2020.105426
   PubMed Web of Science ®Google Scholar
• Saydam M, Timur SS, Vural İ, et al. Cell culture and pharmacokinetic evaluation of a solid dosage formulation containing a water-insoluble orphan drug manufactured by FDM-3DP technology. Int J Pharmaceut. 2022;628:122307. doi: 10.1016/j.ijpharm.2022.122307
   PubMed Web of Science ®Google Scholar
• Wirshing DA, Buckley PF. Schizophrenia Treatment Challenges. Psychiatric Times. 2003;20. https://www.psychiatrictimes.com/view/schizophrenia-treatment-challenges
   Google Scholar
• Lee J-H, Park C, Song I-O, et al. Investigation of patient-centric 3D-Printed orodispersible films containing amorphous aripiprazole. Pharmaceuticals. 2022;15(7):895. doi: 10.3390/ph15070895
   Web of Science ®Google Scholar
• Oh B-C, Jin G, Park C, et al. Preparation and evaluation of identifiable quick response (QR)-coded orodispersible films using 3D printer with directly feeding nozzle. Int J Pharmaceut. 2020;584:119405. doi: 10.1016/j.ijpharm.2020.119405
   PubMed Web of Science ®Google Scholar
• Łyszczarz E, Brniak W, Szafraniec-Szczęsny J, et al. The impact of the preparation method on the properties of orodispersible films with Aripiprazole: electrospinning vs. Casting and 3D printing methods. Pharmaceutics. 2021;13(8):1122. doi: 10.3390/pharmaceutics13081122
   PubMed Web of Science ®Google Scholar
• Bhatt U, Malakar TK, Murty US, et al. 3D printing of immediate-release tablets containing olanzapine by filaments extrusion. Drug Dev Ind Pharm. 2021;47(8):1200–1208. doi: 10.1080/03639045.2021.1879833
   PubMed Web of Science ®Google Scholar
• Cho H-W, Baek S-H, Lee B-J, et al. Orodispersible polymer films with the poorly water-soluble drug, olanzapine: hot-melt pneumatic extrusion for single-process 3D printing. Pharmaceutics. 2020;12(8):692. doi: 10.3390/pharmaceutics12080692
   PubMed Web of Science ®Google Scholar
• Rahman S, Marwaha RH StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Apr 18]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK560892/
   Google Scholar
• Solanki NG, Tahsin M, Shah AV, et al. Formulation of 3D printed tablet for rapid drug release by fused deposition modeling: screening polymers for drug release, drug-polymer miscibility and printability. J Pharmaceut sci. 2018;107(1):390–401. doi: 10.1016/j.xphs.2017.10.021
   PubMed Web of Science ®Google Scholar
• Wei C, Solanki NG, Vasoya JM, et al. Development of 3D printed tablets by fused deposition modeling using Polyvinyl alcohol as polymeric matrix for rapid drug release. J Pharmaceut sci. 2020;109(4):1558–1572. doi: 10.1016/j.xphs.2020.01.015
   PubMed Web of Science ®Google Scholar
• Henry S, De Vadder L, Decorte M, et al. Development of a 3D-Printed dosing platform to aid in zolpidem withdrawal therapy. Pharmaceutics. 2021;13(10):1684. doi: 10.3390/pharmaceutics13101684
   PubMed Web of Science ®Google Scholar
• Adamov I, Stanojević G, Medarević D, et al. Formulation and characterization of immediate-release oral dosage forms with zolpidem tartrate fabricated by digital light processing (DLP) 3D printing technique. Int J Pharmaceut. 2022;624:122046. doi: 10.1016/j.ijpharm.2022.122046
   PubMed Web of Science ®Google Scholar
• Callede N, Masciotti T, Casettari L, et al. Development and evaluation of a 3D printing protocol to produce zolpidem-containing printlets, as compounding preparation, by the pressurized-assisted microsyringes technique. Int J Pharmaceut. 2022;621:121756. doi: 10.1016/j.ijpharm.2022.121756
   PubMed Web of Science ®Google Scholar
• Tabriz AG, Mithu MS, Antonijevic MD, et al. 3D printing of LEGO® like designs with tailored release profiles for treatment of sleep disorder. Int J Pharmaceut. 2023;632:122574. doi: 10.1016/j.ijpharm.2022.122574
   PubMed Web of Science ®Google Scholar
• Zhao X, Wei W, Niu R, et al. 3D printed intragastric floating and sustained-release tablets with air chambers. J Pharmaceut sci. 2022;111(1):116–123. doi: 10.1016/j.xphs.2021.07.010
   PubMed Web of Science ®Google Scholar
• Figueiredo S, Fernandes AI, Carvalho FG, et al. Performance and paroxetine stability in tablets manufactured by fused deposition modelling-based 3D printing. J Pharm Pharmacol. 2022;74(1):67–76. doi: 10.1093/jpp/rgab138
   PubMed Web of Science ®Google Scholar
• Chaiwarit T, Aodsab N, Promyos P, et al. Fabrication of Hydroxypropyl methylcellulose orodispersible film loaded mirtazapine using a syringe extrusion 3D printer. Sci Pharm. 2022;90(4):68. doi: 10.3390/scipharm90040068
   Web of Science ®Google Scholar
• Suttrup I, Warnecke T. Dysphagia in Parkinson’s Disease. Dysphagia. 2016;31(1):24–32. doi: 10.1007/s00455-015-9671-9
   PubMed Web of Science ®Google Scholar
• Windolf H, Chamberlain R, Breitkreutz J, et al. 3D printed mini-floating-polypill for Parkinson’s disease: combination of levodopa, Benserazide, and pramipexole in various dosing for personalized therapy. Pharmaceutics. 2022;14(5):931. doi: 10.3390/pharmaceutics14050931
   PubMed Web of Science ®Google Scholar
• Windolf H, Chamberlain R, Quodbach J. Dose-independent drug release from 3D printed oral medicines for patient-specific dosing to improve therapy safety. Int J Pharmaceut. 2022;616:121555.
   PubMed Web of Science ®Google Scholar
• Gültekin HE, Tort S, Tuğcu-Demiröz F, et al. 3D printed extended release tablets for once daily use: an in vitro and in vivo evaluation study for a personalized solid dosage form. Int J Pharmaceut. 2021;596:120222. doi: 10.1016/j.ijpharm.2021.120222
   PubMed Web of Science ®Google Scholar
• Gültekin HE, Tort S, Acartürk F. An effective technology for the development of immediate release solid dosage forms containing low-dose drug: fused deposition modeling 3D printing. Pharm Res. 2019;36(9):128. doi: 10.1007/s11095-019-2655-y
   PubMed Web of Science ®Google Scholar
• Gültekin HE, Tort S, Acartürk F. Fabrication of three dimensional printed tablets in flexible doses: a comprehensive study from design to evaluation. J Drug Delivery Sci Technol. 2022;74:103538. doi: 10.1016/j.jddst.2022.103538
   Web of Science ®Google Scholar
• Emerging Technology Program [Internet]. 2022 [cited 2023 Mar 13]. Available from: https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/emerging-technology-program
   Google Scholar
• Mandate of the EMA innovation task force (ITF) [Internet]. European Medicines Agency; Human Medicines Research and Development Support Division; 2014. Available from: https://www.ema.europa.eu/en/human-regulatory/research-development/innovation-medicines#ema’s-innovation-task-force-(itf)-section
   Google Scholar
• Conformity assessment procedures for 3D printing and 3D printed products to be used in a medical context for COVID-19 [Internet]. European Commission; 2020 [cited 2023 Mar 13]. Available from: https://ec.europa.eu/docsroom/documents/40562
   Google Scholar
• Technical Considerations for Additive Manufactured Medical Devices. U.S. Department of health and human Services Food and drug administration. Rockville, MD: Center for Devices and Radiological Health. Center for Biologics Evaluation and Research; 2017.
   Google Scholar
• U.S. Food and Drug Administration’s (FDA’s). Center for devices and Radiological health. Discussion paper: 3D printing medical devices at the point of care [Internet]. 2021 [cited 2023 Mar 15]. Available from: https://www.fda.gov/medical-devices/3d-printing-medical-devices/3d-printing-medical-devices-point-care-discussion-paper
   Google Scholar
• Consultation on Point of Care manufacturing [Internet]. [cited 2023 Mar 15]. Available from: https://www.gov.uk/government/consultations/point-of-care-consultation/consultation-on-point-of-care-manufacturing
   Google Scholar
• Committee to Identify Innovative Technologies to Advance Pharmaceutical Manufacturing, Board on Chemical Sciences and Technology, Division on Earth and Life Studies, et al. Innovations in pharmaceutical manufacturing on the horizon: technical challenges, regulatory issues, and recommendations [Internet]. WA (D.C): National Academies Press; 2021 [cited 2023 Mar 15]. p. 26009. Available from: https://www.nap.edu/catalog/26009
   Google Scholar
• Guideline on Real time release Testing (formerly guideline on Parametric release). European Medicines Agency; 2012. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-real-time-release-testing-formerly-guideline-parametric-release-revision-1_en.pdf
   Google Scholar
• Trenfield SJ, Goyanes A, Telford R, et al. 3D printed drug products: non-destructive dose verification using a rapid point-and-shoot approach. Int J Pharmaceut. 2018;549(1–2):283–292. doi: 10.1016/j.ijpharm.2018.08.002
   PubMed Web of Science ®Google Scholar
• Kara A, Cerda JR, Yuste I, et al. 3D printing technologies for personalized drug delivery. Emerging Drug Delivery And Biomedical Engineering Technologies [Internet]. 1st ed. Boca Raton: CRC Press; 2023 [cited 2023 Nov 7]. p. 31–47. Available from: https://www.taylorfrancis.com/books/9781003224464/chapters/10.1201/9781003224464-3
   Google Scholar
• Ghanizadeh Tabriz A, Nandi U, Hurt AP, et al. 3D printed bilayer tablet with dual controlled drug release for tuberculosis treatment. Int J Pharmaceut. 2021;593:120147. doi: 10.1016/j.ijpharm.2020.120147
   PubMed Web of Science ®Google Scholar
• Vasiliadis AV, Koukoulias N, Katakalos K. From three-dimensional (3D)- to 6D-Printing technology in orthopedics: science fiction or scientific reality? JFB. 2022;13(3):101. doi: 10.3390/jfb13030101
   Google Scholar
• Georgantzinos SK, Giannopoulos GI, Bakalis PA. Additive manufacturing for effective smart structures: the idea of 6D printing. J Compos Sci. 2021;5(5):119. doi: 10.3390/jcs5050119
   Google Scholar
• Srivastava S, Pandey VK, Singh R, et al. Recent insights on advancements and substantial transformations in food printing technology from 3 to 7D. Food Sci Biotechnol [Internet]. 2023 [[cited 2023 Aug 25]; Available from];32:(13).1783–1804. doi: 10.1007/s10068-023-01352-8
   PubMed Web of Science ®Google Scholar